Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals
Emersom Cicilini Mesquita(D’Or Institute for Research and Education), Fernando A. Bozza(D’Or Institute for Research and Education), Andrew S. Weyrich(Oklahoma Medical Research Foundation), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Lohanna Palhinha(Fundação Oswaldo Cruz), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Lara E. Coelho(UCLA Medical Center), Eugênio D. Hottz(Universidade Federal de Juiz de Fora), Guy A. Zimmerman(University of Utah), Rodrigo T. Amâncio(Universidade Federal do Rio de Janeiro), Matthew T. Rondina(University of Utah)
Cited by 73
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891